These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2514310)

  • 1. [Effect of urinary material and glycosaminoglycans on calcium oxalate monohydrate crystal aggregation].
    Shirane Y; Yamamoto A; Mizuta K; Kagawa S
    Nihon Hinyokika Gakkai Zasshi; 1989 Jul; 80(7):1000-3. PubMed ID: 2514310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of glycosaminoglycans on calcium oxalate crystal aggregation.
    Shirane Y; Yamamoto A; Mizuta K; Kagawa S
    Tokushima J Exp Med; 1989 Dec; 36(3-4):81-5. PubMed ID: 2517714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Urinary material affecting calcium oxalate monohydrate stone formation].
    Shirane Y; Yamamoto A; Mizuta K; Hiraishi K; Kurokawa K; Kagawa S
    Nihon Hinyokika Gakkai Zasshi; 1989 Jul; 80(7):995-9. PubMed ID: 2607720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the possible role of glycosaminoglycans as natural inhibitors of calcium oxalate stones.
    Sallis JD; Lumley MF
    Invest Urol; 1979 Jan; 16(4):296-9. PubMed ID: 429124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Separate effects of urinary chondroitin sulphate and heparan sulphate on the crystallization of urinary calcium oxalate: differences between stone formers and normal control subjects.
    Shum DK; Gohel MD
    Clin Sci (Lond); 1993 Jul; 85(1):33-9. PubMed ID: 8149691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does urine from stone-formers contain macromolecules which promote the crystal growth rate of calcium oxalate crystals in vitro?
    Gjaldbaek JC; Robertson WG
    Clin Chim Acta; 1980 Nov; 108(1):75-80. PubMed ID: 6778638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrophoretic separation and characterization of urinary glycosaminoglycans and their roles in urolithiasis.
    Gohel MD; Shum DK; Tam PC
    Carbohydr Res; 2007 Jan; 342(1):79-86. PubMed ID: 17145044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of glycosaminoglycans on calcium oxalate crystal formation].
    Shirane Y; Hamao T; Kagawa S
    Nihon Hinyokika Gakkai Zasshi; 1990 Jul; 81(7):1065-70. PubMed ID: 2214470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of pH on the urinary inhibition of calcium oxalate crystal growth.
    Tiselius HG
    Br J Urol; 1981 Oct; 53(5):470-4. PubMed ID: 6793122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surface interaction between glycosaminoglycans and calcium oxalate.
    Angell AH; Resnick MI
    J Urol; 1989 May; 141(5):1255-8. PubMed ID: 2709520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of urinary macromolecules and chondroitin sulphate on calcium oxalate crystallization in urine.
    Rodgers AL; Ball D; Harper W
    Scanning Microsc; 1994 Mar; 8(1):71-7. PubMed ID: 7973501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does urinary oxalate interfere with the inhibitory role of glycosaminoglycans and semisynthetic sulfated polysaccharides in calcium oxalate crystallization?
    Cao LC; Deng G; Boevé ER; Romijn JC; de Bruijn WC; Verkoelen CF; Schröder FH
    Eur Urol; 1997; 31(4):485-92. PubMed ID: 9187912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Urinary low molecular promoter of calcium oxalate monohydrate crystal aggregation, preliminary report].
    Shirane Y; Hiraishi K; Kurokawa K
    Nihon Hinyokika Gakkai Zasshi; 1987 Jul; 78(7):1149-54. PubMed ID: 3682505
    [No Abstract]   [Full Text] [Related]  

  • 14. Urinary macromolecular substances as natural inhibitors of calcium oxalate crystal aggregation.
    Koide T; Takemoto M; Itatani H; Takaha M; Sonoda T
    Invest Urol; 1981 Mar; 18(5):382-6. PubMed ID: 6162821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of urine on "in vitro" crystallization rate of calcium oxalate: determination of inhibitory activity by a [14C]oxalate technique.
    Ligabue A; Fini M; Robertson WG
    Clin Chim Acta; 1979 Oct; 98(1-2):39-46. PubMed ID: 227625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macromolecular inhibitors of calcium oxalate crystal growth and aggregation.
    Brockis JG; Bowyer RC; McCulloch RK
    Scand J Urol Nephrol Suppl; 1980; 53():67-74. PubMed ID: 6938008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seeking consistency for the role of urinary macromolecules and glycosaminoglycans in calcium oxalate crystallization processes pertaining to the risk of renal stone formation using a multi-faceted basic science approach.
    Jappie D; Rodgers A; Webber D; Danny I Gohel M
    Clin Chim Acta; 2021 Oct; 521():76-84. PubMed ID: 34197796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strong inhibition of crystal-cell attachment by pediatric urinary macromolecules: a close relationship with high urinary citrate secretion.
    Miyake O; Kakimoto K; Tsujihata M; Yoshimura K; Takahara S; Okuyama A
    Urology; 2001 Sep; 58(3):493-7. PubMed ID: 11549512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of serum on the crystallization of calcium oxalate in whole human urine: inhibition disguised as apparent promotion.
    Edyvane KA; Ryall RL; Mazzachi RD; Marshall VR
    Urol Res; 1987; 15(2):87-92. PubMed ID: 3590435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary macromolecules are promoters of calcium oxalate nucleation in human urine: turbidimetric studies.
    Rodgers AL; Ball D; Harper W
    Clin Chim Acta; 1993 Nov; 220(2):125-34. PubMed ID: 8111957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.